English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1966]
News [3746]
Articles [98]
Editorials [5]
Conferences [165]
elearning [19]
New insight in to role of immune system in colorectal cancer
New insight in to role of immune system in colorectal cancer
ESMO 2025: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer
ESMO 2025: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer
ESMO 2025: Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer
ESMO 2025: Study finds COVID-19 mRNA vaccine sparks immune response to fight cancer
ESMO 2025: ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for immune checkpoint inhibitors
ESMO 2025: ADC improves outcomes for patients with advanced triple-negative breast cancer who are ineligible for...
ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease
ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease
ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC
ESMO 2025: Chemo combination boosts overall survival in patients with EGFR-mutant NSCLC
ESMO 2025: Thymic health linked to immunotherapy response
ESMO 2025: Thymic health linked to immunotherapy response
From molecular pathways to potential treatments: Targeting epithelial‒mesenchymal transition in glioblastoma
From molecular pathways to potential treatments: Targeting epithelial‒mesenchymal transition in glioblastoma
New combination therapy shows promise for aggressive lymphoma resistant to immunotherapy
New combination therapy shows promise for aggressive lymphoma resistant to immunotherapy
Novel biomarker for prognosis and immunotherapy response in head and neck cancer
Novel biomarker for prognosis and immunotherapy response in head and neck cancer
<1…678910…375>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top